Pharmacology and mechanisms of apigenin in preventing osteoporosis
Osteoporosis (OP) stands as the most prevalent systemic skeletal condition associated with aging. The current clinical management of OP predominantly depends on anti-resorptive and anabolic agents. Nevertheless, prolonged use of some of these medications has been observed to reduce efficacy and elev...
Saved in:
| Main Authors: | Sun Lin, Wang Yincang, Du Jiazhe, Xu Xilin, Xiaofeng Zhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-12-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2024.1486646/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Protective effects of apigenin in neurodegeneration: An update on the potential mechanisms
by: Ali Mohammadkhanizadeh, et al.
Published: (2025-03-01) -
Alteration in biochemical parameters in the brain of transgenic Drosophila melanogaster model of Parkinson’s disease exposed to apigenin
by: Yasir Hasan Siddique, et al.
Published: (2017-09-01) -
Pharmacological mechanism of natural products to treat osteoporosis: a focus on the autophagy
by: Chenglong Xin, et al.
Published: (2025-08-01) -
Synthesis and Antioxidant Activity of Selenized Apigenin
by: Yawen GAO, et al.
Published: (2025-02-01) -
Apigenin as a multifaceted antifibrotic agent: Therapeutic potential across organ systems
by: Xiaoyong Hu, et al.
Published: (2025-06-01)